Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis
Conclusion
NOACs are comparable to warfarin in terms of bleeding complications. However, dabigatran therapy is potentially associated with a higher risk of silent cerebral lesions on MRI. The results of this study should be considered as hypothesis-generating and assessed further in prospective randomized clinical studies.
Source: Cardiology and Therapy - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Coumadin | Heart | Ischemic Stroke | MRI Scan | Pradaxa | Stroke | Study | Warfarin